Erratum to “Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse model” [Heliyon 5 (9), (September 2019), e02260]
Clara J. Sei, Bong-Akee Shey, Richard F. Schuman and 6 more
Heliyon · 2019
doi:10.1016/j.heliyon.2019.e02627 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
In the original published version of this article, the subheading for section 2.1, “Mycobacterium smegmatis (SMEG)”, was missing italics. This error was introduced during the typesetting of the article, the publisher apologises for this error. Both the HTML and PDF versions of the article have been updated to correct the error. Opsonic monoclonal antibodies enhance phagocytic killing activity and clearance of Mycobacterium tuberculosis from blood in a quantitative qPCR mouse modelSei et al.HeliyonSeptember 8, 2019In BriefPatients with impaired immunity often have rapid progression of tuberculosis (TB) which can lead to highly lethal Mycobacterium tuberculosis (MTB) sepsis. Opsonic monoclonal antibodies (MABs) directed against MTB that enhance phagocytic killing activity and clearance of MTB from blood may be useful to enhance TB immunity. Full-Text PDF Open Access
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.